Mona Irene Pedersen

440 total citations
17 papers, 299 citations indexed

About

Mona Irene Pedersen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mona Irene Pedersen has authored 17 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Mona Irene Pedersen's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (9 papers). Mona Irene Pedersen is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (9 papers). Mona Irene Pedersen collaborates with scholars based in Norway, Denmark and United States. Mona Irene Pedersen's co-authors include Lill‐Tove Busund, Sigve Andersen, Tom Dønnem, Roy M. Bremnes, Elin Richardsen, Mehrdad Rakaee, Samer Al‐Saad, Thomas K. Kilvær, Nora Ness and Yngve Nordby and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Applied Physiology.

In The Last Decade

Mona Irene Pedersen

17 papers receiving 297 citations

Peers

Countries citing papers authored by Mona Irene Pedersen

Since Specialization

Citations

This map shows the geographic impact of Mona Irene Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Irene Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Irene Pedersen more than expected).

Fields of papers citing papers by Mona Irene Pedersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Irene Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Irene Pedersen. The network helps show where Mona Irene Pedersen may publish in the future.

Co-authorship network of co-authors of Mona Irene Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Irene Pedersen. A scholar is included among the top collaborators of Mona Irene Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Irene Pedersen. Mona Irene Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Roles of miR-20a-5p in breast cancer based on the clinical and multi-omic (CAMO) cohort and in vitro studies 2024 ·Scientific Reports ·(unknown), (unknown), Marko Lukic, (unknown), Lill‐Tove Busund, Mona Irene Pedersen, (unknown), Karina Standahl Olsen	2
2	High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC 2024 ·Frontiers in Immunology ·(unknown), Thomas K. Kilvær, Mona Irene Pedersen, Egil Støre Blix, Ilona Urbárová, Erna‐Elise Paulsen, Mehrdad Rakaee, (unknown), Tom Dønnem, Sigve Andersen	1
3	High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer 2023 ·Cancers ·(unknown), Lill‐Tove Busund, Sigve Andersen, Mona Irene Pedersen, (unknown), Thomas K. Kilvær	3
4	Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma 2023 ·Frontiers in Oncology ·Erna‐Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, (unknown), Mette Pøhl, Thomas K. Kilvær, Lill‐Tove Busund, Francesco Pezzella, Tom Dønnem	7
5	High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer 2022 ·Scientific Reports ·(unknown), Sigve Andersen, Mona Irene Pedersen, (unknown), Lill‐Tove Busund, Thomas K. Kilvær	15
6	Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study 2022 ·Cancers ·(unknown), Tom Wilsgaard, Hege Sagstuen Haugnes, Mona Irene Pedersen, Tore Knutsen, (unknown), Edward L. Giovannucci, Anne Elise Eggen, Inger Thune, Elin Richardsen	3
7	High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients 2021 ·Scientific Reports ·(unknown), Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, (unknown), Roy M. Bremnes, Tom Dønnem, (unknown), Thomas K. Kilvær, L. T. Busund, Elin Richardsen	31
8	Overexpression of miR-20a-5p in Tumor Epithelium Is an Independent Negative Prognostic Indicator in Prostate Cancer—A Multi-Institutional Study 2021 ·Cancers ·(unknown), Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, (unknown), Tom Dønnem, (unknown), Thomas K. Kilvær, Lill‐Tove Busund, Elin Richardsen	13
9	Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer 2019 ·Scientific Reports ·Elin Richardsen, Sigve Andersen, Samer Al‐Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen, Nora Ness, (unknown), Ambrogio Fassina, Kristin Austlid Taskén, Ian G. Mills, Tom Dønnem, Roy M. Bremnes, L. T. Busund	28
10	MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer 2019 ·Scientific Reports ·Elin Richardsen, Sigve Andersen, (unknown), Mehrdad Rakaee, Nora Ness, Samer Al‐Saad, Yngve Nordby, Mona Irene Pedersen, Tom Dønnem, Roy M. Bremnes, Lill‐Tove Busund	46
11	A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer 2018 ·Scientific Reports ·(unknown), (unknown), (unknown), Thomas K. Kilvær, Erna‐Elise Paulsen, Mona Irene Pedersen, Tom Dønnem, Sigve Andersen, Roy M. Bremnes, Elin Richardsen, Samer Al‐Saad, Lill‐Tove Busund	25
12	Laeverin protein expression in normal and preeclamptic placentas using tissue microarray analysis 2018 ·Acta Obstetricia Et Gynecologica Scandinavica ·(unknown), Vasilis Sitras, (unknown), Mona Irene Pedersen, Ganesh Acharya	2
13	Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer 2017 ·PLoS ONE ·(unknown), (unknown), Yury Kiselev, Mona Irene Pedersen, (unknown), Tonje Braaten, Lill‐Tove Busund	30
14	Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort 2017 ·PLoS ONE ·Elin Richardsen, Sigve Andersen, Samer Al‐Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen, Nora Ness, (unknown), (unknown), Tom Dønnem, Roy M. Bremnes, Lill‐Tove Busund	39
15	High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome 2014 ·BMC Clinical Pathology ·Helge Stenvold, Tom Dønnem, Sigve Andersen, Samer Al‐Saad, Andrej Valkov, Mona Irene Pedersen, Lill‐Tove Busund, Roy M. Bremnes	22
16	Adrenergic β₁- and β₁₊₂-receptor blockade suppress the natural killer cell response to head-up tilt in humans 1997 ·Journal of Applied Physiology ·Mads Klokker, Niels H. Secher, Per Kongshøj Madsen, Mona Irene Pedersen, Bente Klarlund Pedersen	15
17	The Human Promyelocytic Leukemia Cell (HL-60 Cell) β-Adrenergic Receptor 1988 ·Journal of Leukocyte Biology ·Georg Sager, Berit Bang, Mona Irene Pedersen, Jarle Aarbakke	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact